Outsourcing in Clinical Trials Southern California 2022
Arena International are delighted to announce the return of Outsourcing in Clinical Trials Southern California this September for its 9th Annual event!
Our 2022 programme boasts two full streams;
- Clinical Operations & Outsourcing
- Clinical Trial Technology & Innovation
At the past 2021 event attendees heard from the likes of AbbVie, Pfizer, Arena Pharmaceuticals, Bristol Myers Squibb, Daré Bioscience and many more. Mary Syto, Director of Early Clinical Development at Bristol Myers Squibb, led the Clinical Operations stream on the first day, whilst James Wabby, Executive Director of Regulatory Affairs & Combination Products/Device at AbbVie, headed up the Innovation stream.
Whether you are interested in debating the long term impacts COVID-19 will have on the future of clinical trials, or you want to get stuck into a discussion on best practices for strong CRO communications and building trust, there is something for everyone.
With a more interactive and hands on agenda including debates, workshops, roundtables, fireside chats and more, this event will create an environment where clinical trial teams from across all sizes of sponsor and vendor can work together to manage demands while ensuring patients are safeguarded at all stages.
If you are interested in taking part as an attendee or speaker please get in touch!
See you in La Jolla on 28th & 29th September 2022!
ATTENDEES AT DIRECTOR + LEVEL
ARENA EVENTS – COVID 19 SAFETY PROTOCOLS
MEASURES TO PROTECT
Personal Protective Equipment (PPE)
Items of PPE, such as face masks, gloves and eye screens, will be used by staff if appropriate, in line with local government and health authority advice. We strongly advise delegates to bring and wear a mask at our events, unless you are unable to do so due to health reasons.
Delegates at our events will have access to a qualified first aider. Participants will be asked not to attend if they are feeling unwell, and teams will follow local health authority guidance on detecting and managing anyone who shows symptoms of COVID-19.
Trace and contact
If necessary, Arena Events staff will work with local authorities and venues to trace and contact participants at our events, subject to local privacy regulations.
CLEANING AND SANITISING
Our venue partners will undertake enhanced cleaning before, during and after our events, to ensure the highest standards of hygiene and cleanliness. This includes continuous sanitisation throughout the course of an event, with a focus on high-touch areas such as door handles, restrooms and food and beverage areas.
We will provide hand sanitising stations throughout the event space, and will be encouraging all participants to regularly wash and disinfect their hands.
Our events will make best use of technology to minimise queuing and contact during the registration process, and use PPE to make sure the touch points of badges and registration are as safe as possible.
We will request that participants avoid physical contact, such as handshakes and embraces, promoting alternative ways to greet business partners. The exchange of printed materials, such as business cards and sales brochures, will also be discouraged, with digital alternatives recommended.
Our events will maintain a density of participants in line with local authority regulations and venue or other relevant guidance. This will be managed through one or more control measures, such as pre-show communications to participants, a one-way traffic system (venue applicable), on-site signage and floor markings, and staff to help guide delegates.
Food and beverage stations
The event teams will work closely with venue partners to employ the highest standard of food safety, minimising self-service buffets in favour of pre-packaged food options. If any queuing is anticipated, social distancing will be maintained through the use of floor markings and relevant signage.
Catalent solves today’s clinical trial challenges and develop innovative solutions for the future. Catalent’s commitment to quality and service excellence is evident in its flexible solutions, modern global facilities, and over 25 years’ experience reliably supplying thousands of studies of all sizes and complexities around the world.
Advanced Clinical is a global clinical research services organization, providing CRO, FSP, Strategic Resourcing and Consulting Services for biopharmaceutical and medical device organizations. Our company is committed to improving all lives touched by clinical research and we address the hopes of patients and healthcare professionals with industry-leading services and technology in life sciences. Visit our website to learn more about how we deliver a Better Clinical Experience.
With over 40 years’ experience, 600 beds and locations in NA, EU and Asia, Celerion conducts First-in-Human, clinical Proof-of-Concept and patient dose response studies, cardiovascular safety and NDA-enabling clinical pharmacology research. Celerion provides full study services including statistics, data management and biostatistics (including PK/PD analysis), and bioanalytical services.
CROMSOURCE is an international contract research organization providing a comprehensive services to the pharmaceutical and biotechnology companies. Specializing in clinical development and staffing solutions, we offer a flexible approach to ensure our clients’ unique needs are supported. CROMSOURCE is unparalleled in offering an end-to-end guarantee covering trial timelines, enrollment, and price. CROMSOURCE operates offices across Europe and North America.
Pharm-Olam International delivers cost effective, quality clinical services to pharma and biotech sponsors across all therapeutic areas in more than 40 countries. Since 1994, we have been committed to our objective: to create value for our clients by satisfying their clinical development needs with consistent and dependable solutions and services.
Philips BioTel Research is an industry leader in medical imaging and cardiovascular safety testing for clinical trials.
Philips BioTel Research offers global operational support for cardiovascular monitoring in all therapeutic areas, and advances imaging services in oncology, cardiovascular, metabolic, musculoskeletal, neurologic, and medical device studies. Their experienced research team comprises key opinion leaders, board-certified cardiologists and radiologists, sub-specialty scientists, and highly trained technicians – who acquire, evaluate, and report high-quality data through an efficient, cloud-based infrastructure. Many biopharmaceutical trial sponsors rely on or scientific leaders to help design and optimize their protocols and statistical analysis plans. We have conducted clinical trials contributing to the market approval of nearly 100 new drugs to date.
ObvioHealth is a Virtual Research Organization (VRO) pioneering decentralized clinical research. We launched in 2017, leveraging tech innovation to tackle the inefficiencies in the clinical trial process by designing one of the first patient centric mobile apps and platform, making it possible for people to participate in trials from their homes.
Our technology and team of experienced clinical scientists, clinical operations experts, and visionary health technologists make clinical trials safer, easier, faster, and deliver better data. ObvioHealth is on a constant quest to improve our platform and the clinical trial experience to bring more life-improving innovations to market.
Linical is a public, mid-sized Contract Research Organization headquartered in Japan with a significant presence across North America, Europe, and Asia-Pacific. Linical provides the full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, infectious disease, and CNS. Rather than be all things to the market, this intentional design allows us to provide our clients the right size, right reach, and right team.
At Linical, we are the trusted, global CRO to deliver innovative solutions for even the most complex industry challenges. We provide our clients with the personal attention, flexibility, and reach needed for a continually evolving pharmaceutical and biotech market. We believe in supporting clients throughout their unique clinical development journey, with a shared goal of bringing promising new therapies to patients all over the world.
Linical’s vision is to be the CRO of choice amongst the global, mid-sized CRO market. We will achieve this by continuing to expand our current geographical reach into additional parts of the world, enabling us to thoughtfully partner with our clients anywhere their clinical development endeavors take them. While strategically growing our business, we are committed to maintaining the personal, attentive service our clients, employees, and patients deserve.
Red Nucleus Clinical Research combines the digital experience with health outcomes research bringing all R&D functions together in one place, by creating a mobile platform for both clinical and decentralized, evidence-based research and learning programs. The iTakeControl, fully integrated video capture platform, is purposefully designed to capture critical endpoints in a clinical, and remote or at home setting, with the added video de-identification suite to enable regulatory submissions and review. Our comprehensive platform customizes a mobile health solution for Real World Disease Management, Decentralized Clinical Trial Management, and R&D Management.
Founded in 1989, Biotrial is a leading CRO specialized in Early Development with a wide range of services from Non-Clinical Pharmacology, Phase I studies, Phase II-IV Trial Management, Bioanalysis, Oncology, Data Management, Biostatistics, ECG & Imaging Core Lab (QT/QTc Trials, Psychometric Testing, Imaging, EEG/PSG Assessment), Regulatory Affairs to Medical Writing.
1nHealth Delivers Patient-Centric Online Recruitment.
We believe patient recruitment is about starting conversations. The most important elements: Who you talk to and What you say.
The future is almost certainly a personalized one, and that’s how we approach recruitment today. We exist to reach the right people, and present the study’s messaging that meets them where they are.
We deploy our patient-centric, inclusive targeting using engaging study assets that deliver high volumes of pre-qualified study participants, and it works…for Sponsors, and for Patients.
1nHealth. We Fill Studies.
Schulman IRB and Chesapeake IRB have merged to create Advarra, the premier provider of IRB, IBC and global research compliance services. By integrating our innovative technology and proven regulatory expertise, Advarra helps ensure the highest standards of human research protections. Advarra supports all research phases across all major therapeutic areas.